JSPR · Jasper Therapeutics, Inc.
$0.69
-0.01 (-1.26%)
At close · Aug 31
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$23.28M
Shares
33.27M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding JSPR
11 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 833,391 | $350,858 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 312,032 | $131,365 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 153,206 | $127,008 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 49,896 | $41,364 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 34,109 | $28,276 | 0.00% | Long | 2026-05-31 | |
| Defiance Next Gen SPAC Derived ETF | — | 6,706 | $12,943 | 0.09% | Long | 2022-06-30 | |
| VANGUARD BALANCED INDEX FUND | — | 26,598 | $11,198 | 0.00% | Long | 2026-06-30 | |
| Small-Mid Cap Equity Fund | TSGUX | 414 | $9,443 | 0.00% | Long | 2024-11-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 9,659 | $8,007 | 0.00% | Long | 2026-05-31 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 146 | $137 | 0.00% | Long | 2026-04-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,800 | $758 | 0.00% | Short | 2026-06-30 |
Showing 1–11 of 11 positions
Key facts
CIK
1788028
CUSIP
471871202
13F (30d)
52 filings
51 filers
Visit website
Investor relations